Osteoporosis Screening in 2026: Who Should Get a Bone Density Test and Why It Matters

Why osteoporosis screening matters

Osteoporosis is often called a “silent” disease. Bone loss can happen for years without symptoms—until a fracture occurs. Hip and spine fractures, in particular, can lead to loss of independence, surgery, long recovery times, and in some cases serious complications.

In the United States, osteoporosis affects millions of adults. According to the CDC, about 12% of adults age 50 and older have osteoporosis at the femur neck or lumbar spine, and many more have low bone mass (sometimes called osteopenia), which increases fracture risk. Fractures are especially common among older women.

The practical takeaway: many fractures can be prevented. But prevention starts with identifying who is at high risk.

What the USPSTF recommends in 2026

The U.S. Preventive Services Task Force (USPSTF), an independent panel that reviews evidence on preventive care, recommends:

Screening for osteoporosis in all women age 65 and older.
Screening in younger postmenopausal women who are at increased risk of fracture.

This recommendation carries a Grade B, meaning the Task Force concludes there is moderate certainty that screening has a moderate net benefit for these groups.

For men, however, the USPSTF states that current evidence is insufficient to assess the balance of benefits and harms of routine screening in men without a history of fractures. That does not mean screening never makes sense for men—it means the research is not strong enough to support universal screening. Clinicians often individualize decisions based on risk factors.

How doctors decide who is “at increased risk”

Younger postmenopausal women may qualify for screening if their fracture risk is similar to or higher than that of a typical 65-year-old woman.

Doctors look at clinical risk factors such as:

Low body weight
Prior fracture after age 50
Parental history of hip fracture
Smoking
Excess alcohol use
Long-term steroid use (like prednisone)
Certain medical conditions (such as rheumatoid arthritis)

Clinicians often use tools such as FRAX (Fracture Risk Assessment Tool), which estimates a person’s 10-year risk of hip fracture or major osteoporotic fracture using age, weight, medical history, and sometimes bone density. FRAX is a decision aid—it helps guide conversations but does not replace clinical judgment.

What a DXA scan measures

The standard screening test is a dual-energy X-ray absorptiometry (DXA) scan. It is quick, painless, and uses very low radiation. The test measures bone mineral density (BMD), usually at the hip and lower spine—two common fracture sites.

Results are reported as a T-score:

A T-score of −1.0 or higher is considered normal.
Between −1.0 and −2.5 is low bone mass (osteopenia).
−2.5 or lower is diagnostic for osteoporosis.

A DXA scan alone does not prevent fractures. The benefit comes from identifying people at high risk and, when appropriate, starting treatments that reduce fracture risk.

What the evidence shows—and where it is limited

The USPSTF recommendation is based on a detailed evidence review published in JAMA. That review looked at randomized clinical trials and other studies.

Here’s what we know:

There is evidence that screening older women, followed by appropriate treatment in those at high risk, reduces fractures.
Medications such as bisphosphonates have been shown in randomized trials to reduce hip and vertebral fractures in women with osteoporosis.

However, an important limitation is that there are relatively few trials that directly compare “screening versus no screening.” Much of the benefit evidence comes from trials of treatment in women who were identified as having low bone density. In other words, the pathway is: screening → identify high-risk women → treat → fewer fractures.

For men, the evidence base is thinner. There are treatment trials in men with osteoporosis, but there is limited direct evidence showing that routine screening of all men reduces fractures at the population level. That is why the USPSTF calls the evidence insufficient rather than recommending for or against routine screening in men.

Possible downsides of screening

Screening is generally considered safe, but it is not risk-free in a broader sense.

False positives or overdiagnosis: Some people may be labeled as having osteoporosis or high risk and experience anxiety or start treatment that may not ultimately benefit them.
Medication side effects: Drugs used to treat osteoporosis can have side effects, including gastrointestinal symptoms, rare atypical fractures, or osteonecrosis of the jaw. These are uncommon but real.
Cost and access barriers: Even with insurance coverage, copays or facility fees can be confusing.

That’s why shared decision-making with a clinician is important—especially for people under 65 or men considering screening.

Insurance coverage and Medicare rules

Under the Affordable Care Act, preventive services that receive a Grade A or B recommendation from the USPSTF must generally be covered by most private insurance plans without cost-sharing when provided in-network. Because osteoporosis screening in eligible women has a Grade B recommendation, it is typically covered as preventive care.

For Medicare beneficiaries, Medicare Part B covers bone mass measurements once every 24 months (or more often if medically necessary) for people who meet certain criteria, including women at risk for osteoporosis and people with certain medical conditions or medication exposures.

Coverage details can vary by plan. It’s reasonable to call your insurer or check Medicare.gov to confirm eligibility and any potential out-of-pocket costs.

Warning signs that should prompt a conversation

Even if you are outside the routine screening age range, talk to your clinician if you have:

A fracture from a minor fall after age 50
Noticeable height loss
New or worsening stooped posture
Long-term steroid use

A prior fragility fracture often changes the treatment conversation, regardless of age.

Prevention still matters—for everyone

Whether or not you qualify for screening, bone health is a lifelong issue.

Get adequate calcium and vitamin D through diet and supplements if needed.
Engage in weight-bearing and resistance exercises.
Avoid smoking and limit alcohol.
Reduce fall risks at home (good lighting, secure rugs, vision checks).

Strong bones support mobility, independence, and overall health. Screening is one tool—but daily habits and fall prevention are just as important.

What this means for readers

If you are a woman 65 or older, most experts recommend a bone density test—even if you feel well. If you are a younger postmenopausal woman with risk factors, ask your clinician whether you qualify. For men, decisions should be individualized based on your personal risk profile.

A DXA scan is quick and low radiation. The real benefit comes from using the results to guide smart prevention and, when appropriate, treatment.

As with many preventive services, the goal is not to test everyone—it’s to identify those most likely to benefit and reduce the risk of life-changing fractures before they happen.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.